发明名称 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine (TCPP) and kit for use with detecting cancer
摘要 Presented is a kit containing TCPP for use in prognosing a patient's response to a cancer therapy wherein prior to the therapy contacting a sample of cells from the patient's tissue or organ being treated for the cancer with a solution of TCPP to permit binding of the TCPP to components of the abnormal dysplastic or carcinomic cells, if any are present; detecting TCPP fluorescence in the sample, the presence of TCPP fluorescence being indicative that the sample contains dysplastic or carcinomic cells; at intervals during the therapy and subsequent to the therapy performing steps a-c on another sample of cells from the patient's tissue or organ being treated for the cancer; and determining if the percentage of abnormal pre-cancerous cells in the samples tested during and subsequent to the therapy are reduced as compared with the sample tested prior to the therapy, the reduction being prognostic of the patients response to the cancer therapy.
申请公布号 US9417241(B2) 申请公布日期 2016.08.16
申请号 US201514643194 申请日期 2015.03.10
申请人 BIOAFFINITY TECHNOLOGIES, INC. 发明人 Garwin Jeffrey
分类号 A61K31/409;G01N33/574;G01N33/50;G01N33/52 主分类号 A61K31/409
代理机构 Peacock Myers, P.C. 代理人 Peacock Myers, P.C. ;Vilven Janeen
主权项 1. A kit for detection of dysplastic or cancerous cells in a sample, the kit comprising: 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine (TCPP) in an aqueous alcoholic solution comprising between about 50% and about 90% alcohol, at a pH between about 8.5 and about 12.0, in a container and instructions for its use for detecting of abnormal precancerous or cancerous cells in a sample.
地址 San Antonio TX US
您可能感兴趣的专利